Skip to main content

CHS makes the news


Chediak-Higashi Syndrome, or CHS, is another syndrome similar to Hermansky-Pudlak Syndrome that can occur among people with albinism. CHS involves a lot of additional health issues because the immune system is so compromised. But many CHS'ers are now living longer lives thanks to bone marrow transplants. Here's a young lady in Australia with CHS that made the news.





Shy-Ann kicks off heeling process
Friday, February 22, 2008

EIGHT-year-old Shy-Ann Marshall has a shoe fetish - and with $2000 she can buy all the footwear she wants.

Her wish was granted by the Make-A-Wish Foundation last night when she received $2000 in vouchers to go on a shopping spree in Cairns.

"She loves shopping," Shy-Ann's mum Tianie Healey said.

"She has a shoe fetish and wants to shop for 17 pairs of shoes but I told her with that amount of money she can buy more than just shoes."

Also on the Machans Beach youngster's shopping list are make-up, games, a hair dryer, clothes and a doll's pram.

The bubbly and confident primary school student was diagnosed in 2006 with chediak-higashi syndrome, which means she has no immune system to fight off the common cold and viral diseases like chickenpox, posing a serious threat to her health.

She is the only child in the state with the condition, which leaves her with chronic immune system problems because of her abnormally low white blood-cell count.
Shy-Ann has undergone a bone marrow transplant thanks to elder brother Tajah. Her family spent 13 months in a Brisbane hospital for treatment when she was diagnosed.
"It was a shock," Ms Healey said. "We take her day by day. She’s a little character though."

Shoe in: Make-A-Wish recipient Shy-Ann Marshall has a chance to indulge her shoe fetish with $2000 in Cairns shopping vouchers."

Shoe in: Make-A-Wish recipient Shy-Ann Marshall has a chance to indulge her shoe fetish with $2000 in Cairns shopping vouchers.

Comments

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria